News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synta Pharmaceuticals (SNTA) To Present On Hsp90-inhibitor Drug Conjugate Platform At The 12th International Congress On Targeted Anticancer Therapies


3/3/2014 7:15:39 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the following late-breaking poster presentation will be made at the 12th International Congress on Targeted Anticancer Therapies in Washington, D.C.:

“Hsp90 Inhibitor Drug Conjugates (HDCs): A Novel Drug Delivery Platform Technology”

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES